Multitrait analysis of glaucoma identifies new risk loci and enables polygenic prediction of disease susceptibility and progression

Jamie E. Craig,Xikun Han,Ayub Qassim,Mark Hassall,Jessica N. Cooke Bailey,Tyler G. Kinzy,Anthony P. Khawaja,Jiyuan An,Henry Marshall,Puya Gharahkhani,Robert P. Igo,Stuart L. Graham,Paul R. Healey,Jue-Sheng Ong,Tiger Zhou,Owen Siggs,Matthew H. Law,Emmanuelle Souzeau,Bronwyn Ridge,Pirro G. Hysi,Kathryn P. Burdon,Richard A. Mills,John Landers,Jonathan B. Ruddle,Ashish Agar,Anna Galanopoulos,Andrew J. R. White,Colin E. Willoughby,Nicholas H. Andrew,Stephen Best,Andrea L. Vincent,Ivan Goldberg,Graham Radford-Smith,Nicholas G. Martin,Grant W. Montgomery,Veronique Vitart,Rene Hoehn,Robert Wojciechowski,Jost B. Jonas,Tin Aung,Louis R. Pasquale,Angela Jane Cree,Sobha Sivaprasad,Neeru A. Vallabh,Ananth C. Viswanathan,Francesca Pasutto,Jonathan L. Haines,Caroline C. W. Klaver,Cornelia M. van Duijn,Robert J. Casson,Paul J. Foster,Peng Tee Khaw,Christopher J. Hammond,David A. Mackey,Paul Mitchell,Andrew J. Lotery,Janey L. Wiggs,Alex W. Hewitt,Stuart MacGregor,,
DOI: https://doi.org/10.1038/s41588-019-0556-y
IF: 30.8
2020-01-20
Nature Genetics
Abstract:Glaucoma, a disease characterized by progressive optic nerve degeneration, can be prevented through timely diagnosis and treatment. We characterize optic nerve photographs of 67,040 UK Biobank participants and use a multitrait genetic model to identify risk loci for glaucoma. A glaucoma polygenic risk score (PRS) enables effective risk stratification in unselected glaucoma cases and modifies penetrance of the <i>MYOC</i> variant encoding p.Gln368Ter, the most common glaucoma-associated myocilin variant. In the unselected glaucoma population, individuals in the top PRS decile reach an absolute risk for glaucoma 10 years earlier than the bottom decile and are at 15-fold increased risk of developing advanced glaucoma (top 10% versus remaining 90%, odds ratio = 4.20). The PRS predicts glaucoma progression in prospectively monitored, early manifest glaucoma cases (<i>P</i> = 0.004) and surgical intervention in advanced disease (<i>P</i> = 3.6 × 10<sup>−</sup><sup>6</sup>). This glaucoma PRS will facilitate the development of a personalized approach for earlier treatment of high-risk individuals, with less intensive monitoring and treatment being possible for lower-risk groups.
genetics & heredity
What problem does this paper attempt to address?
This paper aims to solve the problems of early diagnosis and risk prediction of glaucoma. Glaucoma is a disease that causes optic nerve degeneration and is the leading cause of irreversible blindness worldwide. Although there are currently some treatment methods that can slow down or stop the progression of the disease, early detection and identification of high - risk individuals remain a major challenge. Through large - scale multi - trait genome - wide association studies (GWAS), the paper discovered new glaucoma risk loci and developed a multi - trait genetic risk score (PRS) for predicting the risk and progression of glaucoma. ### Main problems solved in the paper: 1. **Discover new glaucoma risk loci**: - By analyzing the optic nerve photos of 67,040 UK Biobank participants and combining with multi - trait genetic models, the paper identified new glaucoma risk loci. - Using the multi - trait analysis method (MTAG), the paper discovered 114 independent single - nucleotide polymorphisms (SNPs) in the genome - wide association study, of which 49 are new loci that have not been discovered before. 2. **Develop multi - trait genetic risk score (PRS)**: - Based on the results of multi - trait analysis, the paper developed a multi - trait genetic risk score (PRS) for glaucoma, which can effectively distinguish glaucoma patients with different risk levels. - The PRS has been validated in multiple independent cohorts, showing its high predictive ability. For example, in the Australian and New Zealand Advanced Glaucoma Registry (ANZRAG) cohort, the PRS can significantly distinguish high - risk and low - risk individuals. 3. **Evaluate the application value of PRS in clinical practice**: - Research shows that the PRS can predict the early onset and progression rate of glaucoma. In early glaucoma patients, the PRS is significantly correlated with the loss ratio and rate of the retinal nerve fiber layer (RNFL). - The PRS can also predict high - risk patients who need surgical treatment. In the ANZRAG cohort, individuals with the highest PRS scores are more likely to need glaucoma surgery (such as trabeculectomy). 4. **Optimize the screening strategy for the general population**: - The research proposes a PRS - based screening strategy, which can more effectively identify high - risk individuals within a specific age range (such as 50 - 60 years old), thereby improving the efficiency and cost - effectiveness of screening. - In the Blue Mountains Eye Study (BMES) data, by screening only the top 10% of individuals with the highest PRS scores, 40% of early cases can be identified. ### Conclusion: Through large - scale multi - trait genome - wide association studies, this paper not only discovered new glaucoma risk loci, but also developed an effective multi - trait genetic risk score (PRS). This scoring system has shown good predictive ability in multiple independent cohorts, can effectively distinguish high - risk and low - risk individuals, and is helpful for early diagnosis and the formulation of personalized treatment strategies. In addition, the PRS - based screening strategy is expected to improve the efficiency and cost - effectiveness of glaucoma screening.